Pharmacogenetic testing in the treatment of type 2 diabetes with sulfonylurea drugs

Pharmacogenetic testing in the treatment of type 2 diabetes with sulfonylurea drugs

The article analyses scientific literature on the use of pharmacogenetic testing to optimize sulfonylurea treatment of patients with type 2 diabetes. It describes characteristics of modern sulfonylurea drugs used in the treatment of type 2 diabetes, including their mode of action, and the frequency...

Full description

Bibliographic Details
Main Authors:	G. I. Gorodetskaya, V. G. Kukes, S. A. Belkov, R. E. Kazakov, S. Yu. Serebrova, O. V. Muslimova, T. A. Rodina, A. A. Aleksandrov
Format:	Article
Language:	Russian
Published:	NEICON ISP LLC 2018-02-01
Series:	Ведомости Научного центра экспертизы средств медицинского применения
Subjects:	сахарный диабет 2 типа гипогликемия препараты сульфонилмочевины полиморфизмы генов лозартановый тест type 2 diabetes hypoglycaemia sulfonylureas gene polymorphisms losartan test
Online Access:	https://www.vedomostincesmp.ru/jour/article/view/146

Similar Items

Vliyanie glimepirida (Amarila) na sostoyanie lipidnogo obmena, perekisnoe okislenie lipidov i insulinrezistentnost'
by: Mikhail Ivanovich Balabolkin, et al.
Published: (2003-09-01)

Vzaimosvyaz' mezhdu avtonomnoy nevropatiey i bessimptomnymi gipoglikemiyami u patsientov s sakharnym diabetom 1 tipa
by: O V Svetlova, et al.
Published: (2008-12-01)

Beta-adrenoblokatory pri serdechnoy nedostatochnosti u bol'nykh sakharnym diabetom 2 tipa: karvedilol i risk gipoglikemiy
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2008-03-01)

O lechenii sakharnogo diabeta 2 tipa glimepiridom
by: Ashot Musaelovich Mkrtumyan
Published: (2000-12-01)

Vliyanie preparatov sul'fonilmocheviny na serdechno-sosudistuyu sistemu
by: Marina Vladimirovna Shestakova
Published: (2007-03-01)

Pharmacogenetics in treatment of anthracycline-induced cardiotoxicity in women without prior cardiovascular diseases
by: E. V. Grakova, et al.
Published: (2023-01-01)

Osnovnye printsipy terapii sakharnogo diabeta 2 tipa
by: Ivan Ivanovich Dedov, et al.
Published: (1999-03-01)

Cardiac Autonomic Neuropathy and Hypoglycemia as Independent Predictors of QTc Elongation at Night in Adolescents With Type 1 Diabetes: Cohort Study
by: Alexandra N. Demyanenko, et al.
Published: (2019-11-01)

DISTRIBUTION OF POLYMORPHISMS OF GENES OF STATINS METABOLISM AND TRANSPORT IN THE LIVER IN PATIENTS WITH CORONARY ARTERY DISEASE ETHNIC UZBEKS WITH SIMVASTATIN INTOLERANCE
by: A. B. Shek, et al.
Published: (2017-03-01)

Molecular genetic risk factors for ischemic stroke in patients with thoracoabdominal malignant tumors
by: A. A. Korolyova, et al.
Published: (2023-02-01)

Ezhednevnye dvukratnye in"ektsii dvukhfaznogo insulina asparta bolee effektivno uluchshayut kontrol' postprandial'noy glikemii u bol'nykh diabetom tipa 2, chem ezhednevnye dvukratnye in"ektsii NPKh-insulina, pri nizkom riske gipoglikemii
by: Dzh Kristiansen, et al.
Published: (2004-03-01)

Пациент с гипогликемией на приеме врача общей практики
Published: (2016-12-01)

Гипогликемия и гипогликемическая кома
Published: (2019-09-01)

Качество жизни пациентов с сахарным диабетом типа 2 на фоне комплексной сахароснижающей терапии с использованием глимепирида (Амарила)
Published: (2018-06-01)

Mozhno li izbezhat' polipragmazii pri insulinzavisimom sakharnom diabete?
by: Marina Vladimirovna Shestakova
Published: (1999-03-01)

Analogi insulina (insulin detemir i insulin aspart) v sravnenii s traditsionnymi chelovecheskimi insulinami (NPKh-insulinom i chelovecheskim insulinom korotkogo deystviya) v bazal'no-bolyusnoy terapii bol'nykh sakharnym diabetom 1 tipa
by: K Khermansen, et al.
Published: (2006-03-01)

Restenosis pathophysiological mechanisms and genetic markers after percutaneous coronary interventions
by: Yu. A. Shuvalova, et al.
Published: (2007-10-01)

Androgennyy defitsit u muzhchin s sakharnym diabetom 2 tipa i ego korrektsiya preparatami testosterona
by: Alexander Sergeevich Ametov, et al.
Published: (2007-06-01)

Does A.M. Have a Tumour in the Pancreas?
by: Ursula Gutteck-Amsler, et al.
Published: (2007-04-01)

THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS: RISKS AND PROSPECTS
by: L. Yu. Morgunov
Published: (2017-12-01)

The role of sulfonylures in the treatment of type 2 diabetes
by: L. A. Sharonova, et al.
Published: (2016-12-01)

Sakharosnizhayushchie sul'fanilamidy i ?ishemicheskiy porog? serdtsa u bol'nykh sakharnym diabetom tipa 2 s koronarnoy bolezn'yu serdtsa
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2002-12-01)

Особенности состояния здоровья новорожденных от женщин с компенсированным гестационным сахарным диабетом
by: Анна Ильинична Кузнецова, et al.
Published: (2022-05-01)

Hypoglycemia as a risk factor for sudden death
by: А. S. Pogorelova
Published: (2016-12-01)

Case report - sulfonylurea poisoning mimicking vertebrobasilar acute ischemic stroke
by: Kamila Kędra, et al.
Published: (2023-04-01)

Kontraieptsiya u zhenshchin, bol'nykh sakharnym diabetom 1 i 2 tipa
by: E E Grodnitskaya, et al.
Published: (2003-06-01)

Photodegradation of Flucetosulfuron, a Sulfonylurea-Based Herbicide in the Aqueous Media Is Influenced by Ultraviolet Irradiation
by: Arnab Goon, et al.
Published: (2021-11-01)

Pharmacogenetics of HMG-CoA reductase inhibitors (statins): perspectives of individualized, genotype-based therapy
by: D. A. Sychev, et al.
Published: (2006-02-01)

Design, Synthesis, Molecular Modeling and Anti-Hyperglycemic Evaluation of Quinazoline-Sulfonylurea Hybrids as Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) and Sulfonylurea Receptor (SUR) Agonists
by: Mohamed Ayman El-Zahabi, et al.
Published: (2022-08-01)

FUNCTIONAL CONDITION OF THE CARDIOVASCULAR SYSTEM IN CHILDREN WITH TYPE 1 DIABETES DEPENDING ON THE LEVEL OF GLYCEMIA
by: I. L. Alimova, et al.
Published: (2018-11-01)

Synthesis of sulfonylurea derivatives and their α-glucosidase inhibitory activity
by: Thi Thoi Bui, et al.
Published: (2022-03-01)

Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea
by: Kunavisarut T, et al.
Published: (2019-05-01)

PERSONALIZED STATIN THERAPY IN IMPROVING THE TREATMENT OF CORONARY ARTERY DISEASE AND ATHEROSCLEROSIS
by: U. R. Makhmudova, et al.
Published: (2015-06-01)

Nebivolol i dislipidemiya u bol'nykh sakharnym diabetom 2 tipa
by: Ivan Ivanovich Dedov, et al.
Published: (2001-03-01)

Diabetic nephropathy. Is renoprotection determined by the choice of hypoglycemic therapy?
by: A. Y. Babenko, et al.
Published: (2015-12-01)

Периоперационное ведение взрослых пациентов с сопутствующим сахарным диабетом: методические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов» (второй пересмотр)
by: Igor B. Zabolotskikh, et al.
Published: (2023-01-01)

Expression of genes related to glucose metabolism and joint destruction in the development of diabetes mellitus in patients with osteoarthritis
by: E. V. Chetina, et al.
Published: (2019-03-01)

Diabetes and bone. Focus on DPP-4 inhibitors
by: A. Y. Babenko, et al.
Published: (2015-12-01)

Association of polymorphisms of NO synthases and arginase genes, clinical, laboratory and functional indicators with the level of nitrogen oxide in exhaled air in children with bronchial asthma
by: B. T. Batozhargalova, et al.
Published: (2019-11-01)

ASPIRIN RESISTANCE CANDIDATE GENES AND THEIR ASSOCIATION WITH THE RISK OF CARDIOVASCULAR EVENTS
by: Yu. I. Grinshtein, et al.
Published: (2013-02-01)